Targeting AMPK: A new therapeutic opportunity in breast cancer
- 1 July 2008
- journal article
- review article
- Published by Elsevier BV in Critical Reviews in Oncology/Hematology
- Vol. 67 (1), 1-7
- https://doi.org/10.1016/j.critrevonc.2008.01.007
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Defining the Role of mTOR in CancerCancer Cell, 2007
- Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40Nature, 2007
- Complexity of the TOR signaling networkTrends in Cell Biology, 2006
- TOR Signaling in Growth and MetabolismCell, 2006
- Upstream and downstream of mTORGenes & Development, 2004
- TOR SignalingScience's STKE, 2003
- Mammalian Target of Rapamycin: A New Molecular Target for Breast CancerClinical Breast Cancer, 2003
- TOR signalling in bugs, brain and brawnNature Reviews Molecular Cell Biology, 2003
- The Hallmarks of CancerCell, 2000
- PTEN/MMAC1/TEP1 in signal transduction and tumorigenesisEuropean Journal of Biochemistry, 1999